Gastrointestinal Endoscopy Devices | Medtech 360 | Market Insights | US | 2021
The COVID-19 pandemic will have a limited negative impact on the US GI endoscopy device market; although many screening and elective interventional procedures will be postponed, urgent procedures will continue to be performed. Once the market recovers, it will expand moderately through 2029, due to new treatment and screening guidelines, as well as the introduction of less invasive screening and therapeutic technologies, which will support procedure volumes across the US. However, continued hospital consolidation, reimbursement changes, and the ongoing shift toward value-based care in the US will limit market expansion to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in the US across a 10-year period.
